Relaxing incisions reduce postop astigmatism

Article

Relaxing incisions are a safe and effective method for reducing postoperative astigmatism and help improve visual acuity (VA), according to a study published in the March issue of the Journal of Refractive Surgery.

Relaxing incisions are a safe and effective method for reducing postoperative astigmatism and help improve visual acuity (VA), according to a study published in the March issue of the Journal of Refractive Surgery.

Margareta Claesson, MD and John Armitage, PhD, from the Sahlgrenska University Hospital, Sweden and the University of Bristol, UK, respectively, conducted a study to determine the impact of relaxing incisions for correcting postoperative astigmatism following penetrating keratoplasty.

Data was collected through the Swedish Corneal Transplant Register and, of the 1,161 grafts with complete two-year follow-up, 131 underwent relaxing incisions. Stepwise multiple regression was used to determine the factors that influenced the extent of astigmatism. The change in astigmatism brought about by relaxing incisions was evaluated by subtraction and vector analysis.

In patients who underwent relaxing incisions, astigmatism was reduced from 8.40 D to 3.80 D. The mean difference by subtraction was 4.50 D and vector analysis showed the overall reduction of astigmatism induced by surgery to be 7.90 D. Compared with grafts with no refractive surgery, a trend was seen that suggested corrected VA was improved following relaxing incisions.

It was concluded that relaxing incisions are safe and effective as a method of reducing postoperative astigmatism and may even help improve VA in some cases.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.